Completed
In response to the CARES Act, the National Academies of Sciences, Engineering, and Medicine will establish an ad hoc committee to conduct a study to examine the security of the United States medical product supply chain. The committee will assess and evaluate the dependence of the United States on critical drugs and devices that are sourced or manufactured outside of the United States and provide recommendations to improve the resiliency of the medical supply chain.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.
Discover
Events
Convening Activities
Engage
Work with us